Literature DB >> 24820844

Fading chikungunya fever from India: beginning of the end of another episode?

M Muniaraj1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24820844      PMCID: PMC4069744     

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


× No keyword cloud information.
Sir, Chikungunya fever is an acute febrile illness caused by an arthropod-borne alphavirus, Chikungunya virus (CHIKV). The virus is primarily transmitted to humans by the bite of an infected Aedes species mosquito1. The CHIKV was first detected in southern Tanzania in 1952, after that the virus continued to circulate in West and East Africa at relatively low levels2. The spread of CHIKV throughout South and Southeast Asia, have occurred in three waves. The first wave of outbreaks occurred mainly in South Asian countries such as India and Sri Lanka during the 1960s and 1970s. In comparison, the second wave occurred over the 1980s and 1990s, in Southeast Asian countries, such as Philippines, Thailand, Myanmar and Indonesia. The most recent wave of outbreaks started in 2005 in South Asia. This wave was heralded by successive outbreaks in many islands of Indian Ocean in 2005 and subsequently, there was a massive outbreak of cases in 2006 in India which continued through 20103. After the first wave in 1973, the CHIKV had almost disappeared from India till the end of 20054. Despite affecting millions of people for more than half a century, the chikungunya fever has been neglected4. It has been suggested that the outbreak started in late 2005 was due to social and environmental changes in the affected countries and behavioural and biological changes in vector5. Hence it is important to know whether the chikungunya fever has become endemic or it occurs in epidemic form and then disappears as in the past. In this report, the incidence of chikungunya fever per million populations was calculated for each affected States of India for the period from 2006 to 2011. The data were extrapolated in the map of India (Fig. 1) to determine the State-wise incidence. The overall trend of chikungunya fever in the affected States was also calculated for the period from 2006 to 2011 (Fig. 2). The population of unaffected States were excluded to get more accurate picture. The number of people affected by clinically confirmed chikungunya fever in each State of India was obtained from the National Health Profile of Central Bureau of Health Intelligence6 and the total population in each affected State for the same period was obtained from the Provisional Population Tables of Census of India7.
Fig. 1

Fading intensity of chikungunya fever from India. The coloured boxes indicate the incidence of chikungunya fever in one million people. Numbering in the first map indicates corresponding States described in the text. Legends: Tamil Nadu (1), Kerala (2), Karnataka (3), Andhra Pradesh (4), Maharashtra (5), Orissa (6), Madhya Pradesh (7), Gujarat (8), Rajasthan (9), Delhi (10), Uttar Pradesh (11), Chhattisgarh (12), Jharkhand (13), Bihar (14), West Bengal (15), Haryana (16), Punjab (17), Uttarakhand (18), Himachal Pradesh (19), Jammu & Kashmir (20), Sikkim (21), Meghalaya (22), North Eastern States (23) such as Assam, Arunachal Pradesh, Manipur, Mizoram, Nagaland and Tripura, Goa (24), Lakshadweep (25), Puducherry (26) and Andaman & Nicobar Islands (27).

Source: Ref. 6

Fig. 2

Downward trend of chikungunya fever in India.

Source: Refs 6, 7.

Fading intensity of chikungunya fever from India. The coloured boxes indicate the incidence of chikungunya fever in one million people. Numbering in the first map indicates corresponding States described in the text. Legends: Tamil Nadu (1), Kerala (2), Karnataka (3), Andhra Pradesh (4), Maharashtra (5), Orissa (6), Madhya Pradesh (7), Gujarat (8), Rajasthan (9), Delhi (10), Uttar Pradesh (11), Chhattisgarh (12), Jharkhand (13), Bihar (14), West Bengal (15), Haryana (16), Punjab (17), Uttarakhand (18), Himachal Pradesh (19), Jammu & Kashmir (20), Sikkim (21), Meghalaya (22), North Eastern States (23) such as Assam, Arunachal Pradesh, Manipur, Mizoram, Nagaland and Tripura, Goa (24), Lakshadweep (25), Puducherry (26) and Andaman & Nicobar Islands (27). Source: Ref. 6 Downward trend of chikungunya fever in India. Source: Refs 6, 7. The analysis showed that Karnataka (numbered 3 in the map) was the most affected State during the 2006 outbreak followed by the States which are in the western side of the country, facing the Arabian Sea, starting from Gujarat (8) to Kerala (2) through Maharashtra (5) Lakshadweep (25) and Goa (24). The States which face the Bay of Bengal starting from Tamil Nadu (1) to West Bengal (15) through Puducherry (26) Andhra Pradesh (4), Orissa (6) and Andaman & Nicobar islands (27) were comparably less (approximately ten-fold) affected along with Rajasthan (9), Madhya Pradesh (7), Uttar Pradesh (11) and Delhi (10). Excluding 2007, the Karnataka State seemed to be the hot spot for the chikungunya fever throughout the current epidemic. The three clusters of adjoining States were virtually free from the current outbreak. The first cluster included the northern States such as Punjab (17), Himachal Pradesh (19), Uttarakhand (18) and Jammu & Kashmir (20). The second cluster included the Chhattisgarh (12). The third cluster included, the entire North Eastern States (23) such as Assam, Arunachal Pradesh, Manipur, Mizoram, Nagaland and Tripura excluding Meghalaya (22). Although Jharkhand (13) and Bihar (14) were not affected till 2010, cases were seen 2011 (Fig. 1). The overall trend shows that the incidence of chikungunya fever in one million people declined suddenly from 1581.8 in 2006 to 66.7 in 2007 (Fig. 2). This sudden decline seemed to be due to the alarming awareness created by the print and electronic media about the chikungunya fever and effective vector control and source reduction practices carried out by the concerned State Governments5. With a slight increase in 2008 to 105, the cases started declining to 79.7 in 2009, 28 in 2010 and then to 15.3 million people in 2011. The chikungunya outbreaks which started in the late 2005 in different States of India almost disappeared in 2011. This decline might be due to the effect of herd immunity8. Although this study is limited by the use of data collected by passive reporting, the number of cases reported for each year in the study period is assumed to be a fairly stable proportion of the actual number of cases.
  5 in total

1.  Re-emergence of chikungunya virus in India.

Authors:  V Ravi
Journal:  Indian J Med Microbiol       Date:  2006-04       Impact factor: 0.985

2.  Outbreak and spread of chikungunya.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-11-23

Review 3.  Emergence of chikungunya virus in Indian subcontinent after 32 years: A review.

Authors:  Chandrakant Lahariya; S K Pradhan
Journal:  J Vector Borne Dis       Date:  2006-12       Impact factor: 1.688

4.  Epidemiology and control of chikungunya fever in Singapore.

Authors:  Kaiwei Ho; Li Wei Ang; Boon Hian Tan; Choon Siang Tang; Peng Lim Ooi; Lyn James; Goh Kee Tai
Journal:  J Infect       Date:  2011-03-01       Impact factor: 6.072

Review 5.  Chikungunya fever: an epidemiological review of a re-emerging infectious disease.

Authors:  J Erin Staples; Robert F Breiman; Ann M Powers
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

  5 in total
  13 in total

1.  Chikungunya outbreak in Atmakur village, Medak district, Telangana State, India.

Authors:  Chengappa K Uthappa; Ramesh R Allam; Deepak Gunti; Chava Nalini; Prasada R Udaragudi; Geetha P Tadi; Manoj V Murhekar
Journal:  Indian J Med Res       Date:  2015-12       Impact factor: 2.375

2.  Laboratory surveillance of chikungunya in Madhya Pradesh, India (2016-2017).

Authors:  Piyush Joshi; Pragya Yadav; Devendra Mourya; Lalit Sahare; Mahendra Ukey; Rameshwar Khedekar; Deepak Patil; Pradip V Barde
Journal:  Indian J Med Res       Date:  2020-01       Impact factor: 2.375

3.  Chikungunya Outbreaks in India: A Prospective Study Comparing Neutralization and Sequelae during Two Outbreaks in 2010 and 2016.

Authors:  Jaspreet Jain; Navjot Kaur; Sherry L Haller; Ankit Kumar; Shannan L Rossi; Vimal Narayanan; Dilip Kumar; Rajni Gaind; Scott C Weaver; Albert J Auguste; Sujatha Sunil
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

4.  Antibody response patterns in chikungunya febrile phase predict protection versus progression to chronic arthritis.

Authors:  Kaustuv Nayak; Vineet Jain; Manpreet Kaur; Naushad Khan; Kamalvishnu Gottimukkala; Charu Aggarwal; Rohit Sagar; Shipra Gupta; Ramesh Chandra Rai; Kritika Dixit; Mohammad Islamuddin; Wajihul Hasan Khan; Anil Verma; Deepti Maheshwari; Yadya M Chawla; Elluri Seetharami Reddy; Harekrushna Panda; Pragati Sharma; Priya Bhatnagar; Prabhat Singh; Siva Raghavendhar B; Ashok Kumar Patel; Vinod H Ratageri; Anmol Chandele; Pratima Ray; Kaja Murali-Krishna
Journal:  JCI Insight       Date:  2020-04-09

5.  Upsurge of chikungunya cases in Uttar Pradesh, India.

Authors:  Ahmad Ozair; Danish N Khan; Shantanu Prakash; Amit Bhagat; Anil Verma; Suruchi Shukla; Amita Jain
Journal:  Indian J Med Res       Date:  2020-11       Impact factor: 2.375

6.  Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation.

Authors:  Larisa Ivanova; Kai Rausalu; Maksim Ošeka; Dzmitry G Kananovich; Eva Žusinaite; Jaana Tammiku-Taul; Margus Lopp; Andres Merits; Mati Karelson
Journal:  ACS Omega       Date:  2021-04-14

7.  Chikungunya fever outbreak in Guntur, Andhra Pradesh, India.

Authors:  Deepti Parashar; Sarika Amdekar; Ashwini More; Poonam Patil; Reva More; V Ravindra Babu
Journal:  Indian J Med Res       Date:  2015-12       Impact factor: 2.375

8.  Imported Chikungunya Virus Strains, Taiwan, 2006-2014.

Authors:  Cheng-Fen Yang; Chien-Ling Su; Tung-Chien Hsu; Shu-Fen Chang; Chien-Chou Lin; Jason C Huang; Pei-Yun Shu
Journal:  Emerg Infect Dis       Date:  2016-11       Impact factor: 6.883

9.  Serum metabolomics analysis of patients with chikungunya and dengue mono/co-infections reveals distinct metabolite signatures in the three disease conditions.

Authors:  Jatin Shrinet; Jayanthi S Shastri; Rajni Gaind; Neel Sarovar Bhavesh; Sujatha Sunil
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

10.  Antiviral Phosphorodiamidate Morpholino Oligomers are Protective against Chikungunya Virus Infection on Cell-based and Murine Models.

Authors:  Shirley Lam; Huixin Chen; Caiyun Karen Chen; Nyo Min; Justin Jang Hann Chu
Journal:  Sci Rep       Date:  2015-07-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.